Konkurrenz
Unternehmen | Börsenwert | G | R | O | W | T | H |
---|---|---|---|---|---|---|---|
Lonza Group SWX:LONN |
39,09 Mrd. CHF | 2,58 % | 4/6 | 13,52 % | 2,75 % | 19,92 % | UP |
IQVIA Holdings NYSE:IQV |
32,24 Mrd. $ | 10,21 % | 6/6 | 5,83 % | 26,20 % | 16,01 % | UP |
Labcorp Holdings NYSE:LH |
23,11 Mrd. $ | 5,37 % | 5/6 | 9,65 % | -24,79 % | 7,87 % | UP |
SGS SWX:SGSN |
16,28 Mrd. CHF | 0,65 % | 4/6 | 2,77 % | 18,38 % | 12,93 % | UP |
Eurofins Scientific ENXTPA:ERF |
11,18 Mrd. € | 10,14 % | 5/6 | 6,16 % | 17,38 % | 0,10 % | UP |
ICON Public NasdaqGS:ICLR |
13,14 Mrd. $ | 14,84 % | 4/6 | -4,39 % | 45,13 % | 32,59 % | DOWN |
Dr. Reddy's Laboratories BSE:500124 |
1.076,66 Mrd. Rp | 11,32 % | 4/6 | -0,57 % | -2,29 % | -2,97 % | UP |
Catalent NYSE:CTLT |
11,52 Mrd. $ | -5,82 % | 2/6 | 27,69 % | -22,42 % | 0,03 % | UP |
Huadong Medicine SZSE:000963 |
74,00 Mrd. ¥ | 4,38 % | 5/6 | 16,12 % | 13,20 % | 18,23 % | UP |
Charles River Laboratories International NYSE:CRL |
7,75 Mrd. $ | 8,52 % | 4/6 | -1,62 % | 32,29 % | 11,20 % | DOWN |
Pharmaron Beijing SZSE:300759 |
55,09 Mrd. ¥ | 20,75 % | 5/6 | 32,19 % | 64,92 % | 6,08 % | UP |
Hangzhou Tigermed Consulting SZSE:300347 |
53,15 Mrd. ¥ | 10,66 % | 4/6 | 28,05 % | 46,06 % | 2,07 % | UP |
Asymchem Laboratories (Tianjin) SZSE:002821 |
37,72 Mrd. ¥ | 13,51 % | 4/6 | 25,64 % | 44,09 % | 22,99 % | UP |
Livzon Pharmaceutical Group SZSE:000513 |
34,25 Mrd. ¥ | 0,00 % | 0/0 | 5,89 % | -2,63 % | 8,80 % | UP |
Nanjing King-Friend Biochemical Pharmaceutical SHSE:603707 |
18,45 Mrd. ¥ | 0,00 % | 0/0 | 20,50 % | 24,62 % | 31,35 % | DOWN |
Zhejiang Jiuzhou Pharmaceutical SHSE:603456 |
16,60 Mrd. ¥ | 18,08 % | 3/6 | 30,56 % | 51,78 % | -1,12 % | UP |
Porton Pharma Solutions SZSE:300363 |
13,47 Mrd. ¥ | -24,64 % | 4/6 | 437,43 % | -80,00 % | 12,68 % | UP |
Evotec XTRA:EVT |
1,03 Mrd. € | -24,95 % | 1/6 | 94,33 % | -22,62 % | 72,98 % | DOWN |
Viva Biotech Holdings SEHK:1873 |
5,74 Mrd. HK$ | 0,00 % | 0/3 | 0,00 % | 0,00 % | 41,18 % | UP |
Frontage Holdings SEHK:1521 |
2,90 Mrd. HK$ | 62,41 % | 4/6 | 7,10 % | 94,52 % | -18,75 % | UP |